2025 fourth_quarter Filing
Q4Income
$60K
Filed
January 20, 2026
Lobbying Activities
Health IssuesView all
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; drug importation; and drug shortages. Drug pricing proposals. The 340B program. Pharmacy benefit manager reform proposals, issues related to headache and migraine. P.L. 119-21.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Taxation/Internal Revenue CodeView all
Tax issues affecting the pharmaceutical industry including international tax; implementation of PL 119-21. Vaccine excise tax issues and VICP.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (9)
SUSAN HIRSCHMANN
ms MELINDA M MAXFIELD
mr MATTHEW B HOEKSTRA
CHRISTOPHER E. WILCOX
LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings